Looking for an ASX bank stock to buy for franked dividend income in 2026? Here's my pick of the bunch, and why I'd go for a ...

The All Ordinaries Index (ASX: XAO) is in the red today, but that’s not holding back this rebounding ASX All Ords gold stock.

Three of the ASX's best-known healthcare names have all fallen heavily in 2026. Here is the case for each as we enter FY27.

Morgans has a buy rating and $10.60 price target on Collins Foods shares. It said: In our view, CKF reported a solid result ...

The ASX 200 is still in negative territory, but a stronger bank sector has helped the market avoid a heavier fall.

The Bitcoin (CRYPTO: BTC) price has crashed by more than 50% since October. Here’s what’s pressuring the world’s top crypto.

After years in the wilderness, this overlooked ASX biotech stock is winning back believers, with some analysts tipping gains ...

Northern Star Resources Ltd (ASX: NST) has announced it will hit its production guidance and has also appointed a new Chief ...

Morgan Stanley downgraded the ASX tech share to a hold rating with a $10 target on Wednesday. This suggests potential capital ...

Learn More S&P/ASX 200 Index (ASX: XJO) shares are in the red on Thursday, down 0.09% to 8,714.9 points.    As the new ...

ASX lithium ETFs give investors exposure to companies producing lithium, a valuable commodity used in batteries that power ...

This ASX healthcare stock is up 55% in 2026 and pushing higher again after an update on a late-stage prostate cancer trial.